Stock Track | Elevance Health Plunges 5.83% in Pre-Market on 2026 Profit Forecast Below Estimates Due to Elevated Medical Costs
Stock Track
Jan 28
Elevance Health's stock experienced a significant pre-market plunge of 5.83% on Wednesday.
The sharp decline followed the company's release of its 2026 financial outlook, which forecast adjusted profit below Wall Street expectations. The health insurer anticipates that higher medical costs will persist into the year, contributing to the disappointing forecast.
Industry challenges include persistently high costs stemming from changes in Medicaid enrollment and sustained high demand for healthcare services in areas such as behavioral health and specialty drugs. Despite reporting a fourth-quarter adjusted profit that beat estimates, the weaker-than-expected guidance for the coming year drove the negative market reaction.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.